Leadership Overview
Roche has 10 executives leading key functions including operations, financial strategy, regional management, and marketing.
Committed to advancing science to improve lives, Roche delivers innovative healthcare solutions through its dual focus on pharmaceuticals and diagnostics to transform patient care globally.
Committed to advancing science to improve lives, Roche delivers innovative healthcare solutions through its dual focus on pharmaceuticals and diagnostics to transform patient care globally.
Leadership Roles at Roche
Avi Danziger - Chief Executive Officer, Roche (Israel)
Avi Danziger, the Chief Executive Officer, Roche (Israel) at Roche, leads the strategic direction and market execution for the company within the Israeli healthcare sector. Overseeing the entire portfolio of pharmaceuticals and diagnostics, the Chief Executive Officer, Roche (Israel) drives the adoption of personalized healthcare solutions among local medical providers. This leadership role involves building strong relationships with academic institutions and biotechnology partners to foster innovation. Avi Danziger executes market expansion strategies that ensure the availability of cutting-edge treatments for oncology and immunology. By coordinating with global headquarters, the Chief Executive Officer, Roche (Israel) aligns local operations with the company's overarching mission. Through the promotion of early detection and targeted therapy, the Chief Executive Officer, Roche (Israel) significantly impacts patient care standards, ensuring that the company remains a leader in providing advanced medical solutions to the local population.
Katrin Heil - Chief Financial Officer, Cluster Lead Finance & Operations
Katrin Heil, the Chief Financial Officer, Cluster Lead Finance & Operations at Roche, manages the fiscal health and operational oversight of key business clusters. Directing financial planning and analysis, the Chief Financial Officer, Cluster Lead Finance & Operations ensures that capital investments align with long-term research and development goals. This role involves monitoring market trends to mitigate financial risks while identifying opportunities for growth within the diagnostics and pharmaceutical sectors. Katrin Heil executes strategies that balance cost-efficiency with the need for continuous innovation in personalized healthcare. By supervising the financial reporting processes, the Chief Financial Officer, Cluster Lead Finance & Operations provides the transparency necessary for informed decision-making at the executive level. Through rigorous budget management and operational auditing, the Chief Financial Officer, Cluster Lead Finance & Operations secures the financial stability required to sustain the company's global impact on patient outcomes and medical advancement.
Tin Ha - Chief Financial Officer (China)
Tin Ha, the Chief Financial Officer (China) at Roche, oversees all financial operations and strategic planning within the critical Chinese market. Managing the regional fiscal framework, the Chief Financial Officer (China) ensures compliance with local regulatory requirements while driving revenue growth for both pharmaceutical and diagnostic product lines. This leadership role involves collaborating with local healthcare partners to expand market access for innovative medicines. Tin Ha executes financial strategies that support the rapid deployment of diagnostic solutions across the region. By analyzing market dynamics and competitive pressures, the Chief Financial Officer (China) optimizes investment portfolios to maximize regional performance. Through the alignment of local financial objectives with global corporate goals, the Chief Financial Officer (China) strengthens the company's presence in Asia, ensuring that financial resources effectively support the delivery of advanced healthcare solutions to a vast and growing patient population.
Alberto D'Angelo - Director, Finance & Chief Financial Officer
Alberto D'Angelo, the Director, Finance & Chief Financial Officer at Roche, governs the financial architecture and administrative functions of the organization. Directing the development of robust financial models, the Director, Finance & Chief Financial Officer ensures that the company maintains a strong balance sheet to support ongoing investment in biotechnology and personalized medicine. This role involves overseeing internal controls and financial reporting to uphold the highest standards of corporate governance. Alberto D'Angelo executes initiatives that improve cash flow management and operational profitability across various business units. By collaborating with other C-suite leaders, the Director, Finance & Chief Financial Officer aligns financial performance with the broader mission of advancing science. Through the implementation of sophisticated financial systems, the Director, Finance & Chief Financial Officer drives efficiency and provides the necessary fiscal foundation for the company to continue pioneering new treatments for serious diseases.
Amer Malik - Chief Financial Officer & Director, Finance & Business Services Uae
Amer Malik, the Chief Financial Officer & Director, Finance & Business Services Uae at Roche, manages the financial operations and business services within the Middle Eastern market. Directing the regional financial strategy, the Chief Financial Officer & Director, Finance & Business Services Uae ensures that business services support the efficient distribution of diagnostic and pharmaceutical products. This role involves navigating complex regional economic landscapes to maintain profitability and growth. Amer Malik executes financial policies that facilitate collaboration with local healthcare institutions and government entities. By overseeing the integration of business services, the Chief Financial Officer & Director, Finance & Business Services Uae enhances operational agility in the region. Through the careful management of regional assets and investments, the Chief Financial Officer & Director, Finance & Business Services Uae contributes to the company's global objective of improving patient lives through targeted healthcare solutions and innovative medical diagnostics.
Michael Fell - Manager, Area Finance & Chief Financial Officer, Pharma (APAC)
Michael Fell, the Manager, Area Finance & Chief Financial Officer, Pharma (APAC) at Roche, governs the financial health of the pharmaceutical division across the Asia-Pacific region. Directing financial planning and regional resource allocation, the Chief Financial Officer, Pharma (APAC) ensures that the pharmaceutical pipeline receives the necessary funding to address regional health challenges. This role involves monitoring the financial performance of diverse markets to optimize revenue streams and manage operational costs. Michael Fell executes strategies that support the launch of new medicines and the expansion of therapeutic access. By providing financial oversight for regional clinical trials and partnerships, the Chief Financial Officer, Pharma (APAC) facilitates the advancement of medical science. Through the rigorous analysis of regional economic data, the Chief Financial Officer, Pharma (APAC) enables the company to maintain a strong competitive position and deliver innovative pharmaceutical solutions to patients across the APAC region.
Maria del Pilar Camacho - Director, Finance & Administrative & Chief Financial Officer
Maria del Pilar Camacho, the Director, Finance & Administrative & Chief Financial Officer at Roche, oversees the financial and administrative infrastructure of the organization. Directing the implementation of financial policies, the Director, Finance & Administrative & Chief Financial Officer ensures that administrative processes support the company's research and diagnostic goals. This role involves managing the budget and financial reporting to maintain fiscal discipline across all departments. Maria del Pilar Camacho executes administrative improvements that enhance operational efficiency and support the workforce. By collaborating with the executive team, the Director, Finance & Administrative & Chief Financial Officer aligns administrative functions with the company's strategic objectives. Through the management of financial and administrative resources, the Director, Finance & Administrative & Chief Financial Officer provides the necessary support for the company to continue its work in developing innovative medicines and diagnostic solutions that make a meaningful difference in patient care.
Vishal Arora - Chief Operating Officer
Vishal Arora, the Chief Operating Officer at Roche, directs the internal scaling and operational efficiency of the global pharmaceutical and diagnostics divisions. Overseeing the integration of complex supply chains, the Chief Operating Officer ensures that manufacturing processes meet rigorous international standards for quality and safety. This leadership role involves optimizing resource allocation across research and development pipelines to accelerate the delivery of targeted therapies. By streamlining cross-functional workflows, Vishal Arora directly impacts the company's ability to maintain a competitive edge in oncology and immunology markets. Furthermore, the Chief Operating Officer coordinates with regional leads to ensure consistent operational excellence across diverse geographic territories. Through the implementation of advanced data analytics, the Chief Operating Officer enhances production capacity, ultimately supporting the mission to provide life-saving medicines to patients worldwide while maintaining high standards of operational integrity.
Janaina Carignano - Regional Category Manager, Chemicals & Chief Marketing Officer, Reagents (Americas)
Janaina Carignano, the Regional Category Manager, Chemicals & Chief Marketing Officer, Reagents (Americas) at Roche, directs the marketing strategy for diagnostic reagents across the Americas. Overseeing the product lifecycle and market positioning, the Chief Marketing Officer, Reagents (Americas) ensures that diagnostic solutions meet the evolving needs of laboratories and healthcare facilities. This role involves analyzing market trends to develop effective promotional campaigns that highlight the value of early disease detection. Janaina Carignano executes supply chain strategies for chemical components, ensuring the consistent availability of high-quality reagents. By collaborating with regional sales teams, the Chief Marketing Officer, Reagents (Americas) drives market penetration and brand awareness. Through the strategic management of the reagent portfolio, the Chief Marketing Officer, Reagents (Americas) supports the company's commitment to providing comprehensive diagnostic tools that enable precise treatment decisions for patients throughout the Americas.
Kristina Kallasmaa - Chief Marketing Officer & Site Manager
Kristina Kallasmaa, the Chief Marketing Officer & Site Manager at Roche, leads the marketing initiatives and manages the operational site functions. Directing the development of brand strategies, the Chief Marketing Officer & Site Manager ensures that the company's innovative healthcare solutions are effectively communicated to healthcare professionals and patients. This role involves overseeing the daily operations of the site to maintain a productive and safe environment for researchers and staff. Kristina Kallasmaa executes marketing campaigns that emphasize the importance of personalized healthcare and targeted therapies. By managing site-level resources, the Chief Marketing Officer & Site Manager supports the seamless integration of marketing and operational activities. Through the coordination of cross-functional teams, the Chief Marketing Officer & Site Manager drives the company's mission to improve patient outcomes, ensuring that marketing efforts are backed by efficient site operations and a commitment to scientific excellence.
Explore Leadership Teams in Manufacturing
PiSA Farmacéutica is a socially responsible pharmaceutical company based in Mexico, specializing in the production of over 1,500 brands of medications across 17 specialty lines and 14 production plants. With a workforce of around 30,000 employees, the company emphasizes quality, integrity, and transparency in its operations. PiSA also engages in pharmacovigilance and technovigilance to ensure the safety and efficacy of its products. Their intended clients include hospitals and healthcare providers, reflecting their commitment to improving health outcomes.
Company Leadership AT
CR
YP
AJ
Alkem is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company was established in 1973 and is headquartered in Mumbai, India.
Company Leadership SA
YH
AS
Founded in 1954 and headquartered in Greenfield, Indiana, Elanco Animal Health Inc is an animal health company that develops, manufactures, and markets products for companion and food animals.
Company Leadership

PH
KY
Headquartered in Woodbury, Minnesota, Kindeva Drug Delivery is a leading global contract development and manufacturing organization (CDMO) in the pharmaceutical industry. Kindeva provides unique technologies and quality services to its customers, ranging from formulation and product development to commercial manufacturing. Kindeva focuses on complex drug programs, and its current offering spans inhalation drug delivery, transdermal drug delivery, microstructured transdermal systems (microsystems), and connected drug delivery.
Company Leadership DS

BS